Skip to Content

Continuing Education

Advancing Care in Low-Grade Serous Ovarian Cancer: Integrating Molecular Testing into Clinical Decision Making (On-Demand | 2026 NCODA International Fall Summit)

Best Suited For: Pharmacist, Pharmacy Technician, Nurse, Nurse Practitioner, Physician Assistant

CE Credits: 1.0 hour

Activity Description

Low-grade serous ovarian cancer (LGSOC) is a distinct histologic subtype with unique molecular and biological characteristics that inform its treatment approach. This presentation will compare these characteristics with those of other ovarian cancer subtypes and review recommended molecular testing approaches and biomarkers relevant to LGSOC. Participants will explore current and emerging treatment strategies, including biomarker-directed options. Patient-case examples will provide opportunities to interpret molecular testing results and use molecular and clinical factors to guide treatment selection and clinical decision-making.

CE Credit: 1.0 hour
Fee: This activity does not require payment to register.

LOGIN TO NCODA CONNECT FOR THIS CE ACTIVITY

Learning Objectives

  1. Describe the molecular and biological characteristics of low-grade serous ovarian cancer (LGSOC), including key differences from other ovarian cancer subtypes.
  2. Identify recommended molecular testing approaches in ovarian cancer, including biomarkers relevant to LGSOC.
  3. Discuss current and emerging treatment strategies for patients with LGSOC based on molecular and clinical factors.
  4. Interpret molecular testing results from patient-case examples to guide treatment selection and clinical decision-making in LGSOC.

Obtaining CE Credit

To claim CE credit, select Complete Credit Requirements in your LecturePanda registration confirmation email and complete all the steps listed below:

  • Review the course learning materials.
  • Confirm the information you provided at registration.
  • If you’re completing an on-demand activity, watch the CE video in full.
  • Enter the CE code shared near the end of the activity.
  • Complete all required evaluations and CE assessments.

All CE credit requirements must be completed by 11/17/2029. Upon completion, eligible continuing education credit will be submitted to the appropriate accrediting body. Pharmacist and pharmacy technician credit will be reported to ACPE and reflected in your CPE Monitor profile within 24 hours. Reporting timelines for other healthcare professions may vary by accrediting body or state board.

CE information for nurses, nurse practitioners (NPs), and physician assistants (PAs) can be found here.